Quince Therapeutics
NASDAQ: QNCXSouth San Francisco, US · Founded 2012 · California corporation · 2 known investors
Founders & leadership
Quince Therapeutics was founded in 2012 by Stephen Dominy and Casey Lynch.
SD
Stephen DominyCo-founder
CL
Casey LynchCo-founder
CR
Charles RyanExecutive
BH
Brendan HannahExecutive
DT
Dirk ThyeExecutive
KG
Kristen GafricExecutive
Board
DL
David LamondBoard director
IZ
Ilan ZipkinBoard director
UR
Una RyanBoard director
CS
Christopher SennerBoard director
MM
Margi McLoughlinBoard director
JB
June BrayBoard director
Investors · 2
Reported raises · per SEC filings
Form D private placements$226.2M disclosed across 5 of 6 rounds · 2015–2026
▶$7.4MofferedJun 2026 · 66 investors · BiotechnologyRule 506(b)
▶$7.4MofferedJun 2026 · 66 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- David LamondDirector
- Christopher SennerDirector
- Charles RyanExecutive Officer
- Brendan HannahExecutive Officer
- Dirk ThyeExecutive Officer, Director
- Brigette RobertsExecutive Officer, Director
- June BrayDirector
- Offering amount
- $7.4M
- Sales commissions
- $1.8M
- Placement agents
- LifeSci Capital
- First sale
- May 2026
- Incorporated
- Corporation, California
- Federal exemptions
- 06b
▶$114.7MraisedJun 2026 · 27 investors · BiotechnologyRule 506(b)
▶$114.7MraisedJun 2026 · 27 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Dirk ThyeExecutive Officer, Director
- June BrayDirector
- Brendan HannahExecutive Officer
- Brigette RobertsExecutive Officer, Director
- Charles RyanExecutive Officer
- Christopher SennerDirector
- David LamondDirector
- Offering amount
- $186.4M
- Amount sold
- $114.7M
- Sales commissions
- $7.9M
- Placement agents
- LifeSci Capital
- First sale
- May 2026
- Incorporated
- Corporation, California
- Federal exemptions
- 06b
▶$11.5MraisedJul 2025 · 15 investors · BiotechnologyRule 506(b)
▶$11.5MraisedJul 2025 · 15 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Una RyanDirector
- David LamondDirector
- Christopher SennerDirector
- Charles RyanExecutive Officer
- Margi McLoughlinDirector
- June BrayDirector
- Luca BenattiDirector
- Brendan HannahExecutive Officer
- Dirk ThyeExecutive Officer, Director
- Rajiv PatniDirector
- Offering amount
- $21.9M
- Amount sold
- $11.5M
- Sales commissions
- $689.3K
- Placement agents
- Citizens JMP Securities, LLC
- First sale
- Jun 2025
- Incorporated
- Corporation, California
- Federal exemptions
- 06b
▶$84.5MraisedMay 2018 · 36 investors · PharmaceuticalsRule 506(b)
▶$84.5MraisedMay 2018 · 36 investors · Pharmaceuticals
Rule 506(b)Officers, directors & promoters on the filing
- Ilan ZipkinDirector
- Roger QuyDirector
- David LamondDirector
- Kristen GafricExecutive Officer
- Margi McLoughlinDirector
- Casey LynchExecutive Officer, Director
- Stephen DominyDirector
- Offering amount
- $85.6M
- Amount sold
- $84.5M
- First sale
- May 2018
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$7.6MraisedFeb 2017 · 8 investors · PharmaceuticalsRule 506(b)
▶$7.6MraisedFeb 2017 · 8 investors · Pharmaceuticals
Rule 506(b)Officers, directors & promoters on the filing
- Stephen A. DominyDirector
- Casey LynchExecutive Officer, Director
- David LamondDirector
- Ilan ZipkinDirector
- Roger QuyDirector
- Margi McLoughlinDirector
- Kristen GafricExecutive Officer
- Offering amount
- $8M
- Amount sold
- $7.6M
- First sale
- Feb 2017
- Incorporated
- Corporation, Delaware, 2012
- Federal exemptions
- 06b
▶$7.9MraisedJan 2016 · 13 investors · PharmaceuticalsRule 506(b)
▶$7.9MraisedJan 2016 · 13 investors · Pharmaceuticals
Rule 506(b)Officers, directors & promoters on the filing
- Stephen DominyDirector
- Casey LynchExecutive Officer, Director
- Margi McLoughlinDirector
- Kristen GafricExecutive Officer
- David LamondDirector
- Ilan ZipkinDirector
- Offering amount
- $15.9M
- Amount sold
- $7.9M
- First sale
- Dec 2015
- Incorporated
- Corporation, Delaware, 2012
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
In the news
Quince Therapeutics (QNCX) acquires Orphai and secures up to $187M PIPEstocktitan.net · May 2026Frequently asked questions
- Who founded Quince Therapeutics?
- Quince Therapeutics was founded by Stephen Dominy, Casey Lynch in 2012.
- Who are Quince Therapeutics's investors?
- Quince Therapeutics's investors include Foresite Capital, Sofinnova Partners.
- How much funding has Quince Therapeutics raised?
- Quince Therapeutics has disclosed $226.2M raised across 5 of its 6 known rounds.
- Where is Quince Therapeutics headquartered?
- Quince Therapeutics is headquartered in South San Francisco, US.